Skip to Content

Filter by:

Washington Highlights

House, Senate Committees Seek Input on Draft Drug Distribution Bill

October 26, 2012—The Senate Health, Education, Labor, and Pensions (HELP) and House Energy and Commerce committees Oct. 24 released a bipartisan, bicameral discussion draft of legislation to set standards on tracking drugs through the supply chain.

Lawmakers previously considered the topic during negotiations for legislation to reauthorize user fees at the Food and Drug Administration (FDA), though the final law did not include the so-called “track and trace” provisions [see Washington Highlights, June 22].

Observers predicted that the issue may reemerge as part of legislation (H.R. 2405, S. 1855) to reauthorize the Pandemic and All-Hazards Preparedness Act [see Washington Highlights, March 9], but press reports indicate that the group may advance the drug distribution bill as a stand-alone measure if they reach consensus.

The committees are seeking input on a menu of policy options included in the discussion draft on “issues around which developing consensus is most challenging.” Interested stakeholders should submit their written responses—including preferred policy options and explanations, as well as other comments—to staff for the chairs and ranking members of the HELP and Energy and Commerce committees by Nov. 7.


Tannaz Rasouli
Sr. Director, Public Policy & Strategic Outreach
Telephone: 202-828-0525


envelope on a green background

Subscribe to Washington Highlights

RSS icon

Subscribe to RSS

Washington Highlights, a weekly electronic newsletter, features brief updates on the latest legislative and regulatory activities affecting medical schools and teaching hospitals.

Past Issues

For More Information

Jason Kleinman
Sr. Legislative Analyst, Govt. Relations
Telephone: 202-903-0806